Valuation: Jamjoom Pharmaceuticals Factory Company

Market Cap 10.42B 2.78B 2.43B 2.24B 2.06B 3.9B 267B 3.97B 26.72B 10.49B 131B 10.19B 450B P/E 2026 *
20x
P/E 2027 * -
Enterprise Value 10.11B 2.69B 2.35B 2.17B 2B 3.78B 259B 3.84B 25.91B 10.17B 127B 9.88B 436B EV / Sales 2026 *
6.25x
EV / Sales 2027 * 5.35x
Free-Float
39.1%
Yield 2026 *
3.01%
Yield 2027 * 3.34%

Last Transcript: Jamjoom Pharmaceuticals Factory Company

1 day+2.69%
1 week-1.00%
Current month-3.94%
1 month-7.23%
3 months-3.94%
6 months+3.47%
Current year+4.64%
1 week 144.8
Extreme 144.8
150
1 month 144.8
Extreme 144.8
163.7
Current year 125
Extreme 125
163.7
1 year 125
Extreme 125
180.1
3 years 100.2
Extreme 100.2
202.4
5 years 66
Extreme 66
202.4
10 years 66
Extreme 66
202.4
Manager TitleAgeSince
Chief Executive Officer 62 2021-05-14
Director of Finance/CFO 62 2013-01-12
Chief Operating Officer 31 2021-08-31
Director TitleAgeSince
Chairman 66 2022-06-18
Director/Board Member 41 2022-06-18
Director/Board Member 98 2022-06-18
Change 5-day change 1-year change 3-year change Capi.($)
+2.69%-1.00%-17.14%+22.65% 2.7B
+0.46%+2.53%+15.98%+81.88% 48.52B
-0.36%-4.82%+65.56%+115.03% 35.68B
-0.01%-0.95%-3.10%+39.49% 12.09B
+2.06%+0.34%+19.46%+94.32% 11.77B
+1.13%+0.38%+32.83%+126.50% 9.19B
-1.81%-2.85%+45.77%-5.83% 7.06B
-0.17%0.00%+18.91%+37.57% 7.01B
-0.33%+1.43%+3.52%+227.22% 6.77B
+6.39%-0.15%-14.91%+20.63% 5.98B
Average +1.01%+0.02%+16.69%+75.95% 14.68B
Weighted average by Cap. +0.50%-0.33%+26.92%+87.02%

Financials

2026 *2027 *
Net sales 1.62B 431M 376M 347M 319M 605M 41.43B 615M 4.15B 1.63B 20.25B 1.58B 69.8B 1.87B 498M 436M 402M 369M 700M 47.94B 712M 4.8B 1.88B 23.43B 1.83B 80.76B
Net income 521M 139M 121M 112M 103M 195M 13.35B 198M 1.34B 524M 6.52B 510M 22.49B -
Net Debt -317M -84.41M -73.8M -68.08M -62.58M -119M -8.12B -121M -813M -319M -3.97B -310M -13.68B -404M -108M -94.06M -86.77M -79.76M -151M -10.35B -154M -1.04B -406M -5.06B -395M -17.44B
Logo Jamjoom Pharmaceuticals Factory Company
Jamjoom Pharmaceuticals Factory Company SJSC is a Saudi Arabia-based pharmaceutical company, which is primarily focused on developing, manufacturing, and distributing generic pharmaceuticals, cosmetics, and consumer healthcare products. It produces human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhoea, vomiting, and ulcer and acidity, among others. It operates in two segments: The Pharmaceutical products that represents medicines or drugs for the prevention and treatment of diseases, and protection of public health; and The Consumer health products that represents products used to support personal well-being, maintain health, or address specific health-related needs. The Company’s subsidiaries include Al Jamjoom Pharma for Pharmaceutical Industries and Jamjoom Pharmaceutical Industry and Commerce Company Limited and the Company also operates approximately 8 branches.
Employees
-
Date Price Change Volume
26-07-15 SAR 148.90 +2.69% 46,390
26-07-14 SAR 145.00 -1.09% 13,093
26-07-13 SAR 146.60 -0.81% 92,857
26-07-12 SAR 147.80 +0.34% 21,228
26-07-09 SAR 147.30 -1.87% 37,512
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
148.90SAR
Average target price
164.24SAR
Spread / Average Target
+10.30%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4015 Stock